
News|Articles|November 1, 2008
Drug Watch: Agents in late-stage development for the treatment of sleep disorders (November 2008) (PDF)
Agents in late-stage development for the treatment of insomnia and restless legs syndrome (RLS)
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Part D redesign reshapes market
2
The sleep doctor who lives with a disorder he treats
3
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
4
FAQ: What health plans need to know about Medicare's GLP-1 Bridge program ahead of open enrollment
5













